Coming together to address health disparities in oncology clinical trials facing diverse patients in the U.S.
Learn why this initiative is important to Gryt Health and the outcomes we’re looking to achieve in having these crucial discussions.
The Purpose of Diversity in Oncology
Diversity in Oncology fosters courageous conversations about strategies for delivering equitable, high-quality cancer care for all, including clinical trials. This cross-stakeholder, the cross-cultural initiative can take action to make the clinical trial enterprise more inclusive and responsive to populations that are currently underrepresented.
Who should attend Diversity in Oncology
- Local and national community organizations that focus on health equity
- Patients and caregivers
- Healthcare providers
- Clinical trial teams and principal investigators
- Schools of public health
- Anyone interested in discussing health equity in clinical trials
Watch recorded sessions from DiO
Recorded Sessions
3 Videos
Help improve structural change in clinical trial patient equity
